CoChat

Gaucher disease ascertained through a Parkinson's center: Imaging and clinical characterization

Open access
Saunders‐Pullman, Rachel, Hagenah, Johann, Dhawan, Vijay, Stanley, Kaili, Pastores, Gregory, Sathe, Swati, Tagliati, Michele, Condefer, Kelly, Palmese, Christina, Brüggemann, Norbert, Klein, Christine, Roe, AM, Kornreich, Ruth, Ozelius, Laurie, Bressman, Susan · 2010 · Movement Disorders
Cited by 86

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

Among the genes implicated for parkinsonism is glucocerebrosidase (GBA), which causes Gaucher disease (GD). Despite a growing literature that GD may present as parkinsonism, neuroimaging, olfaction, and neuropsychological testing have not been extensively reported. We describe transcranial sonography (TCS), 18F‐fluorodopa (F‐dopa) and fluorodeoxyglucose (FDG) Positron emission tomography, olfaction testing, neuropsychological testing, and clinical features in homozygous and compound heterozygous GBA mutation carriers identified through screening of 250 Ashkenazi Jewish parkinsonian individuals treated at a tertiary care center. We identified two individuals with N370S/R496H compound heterozygous mutations and two with N370S homozygous mutations; one individual died before completing detailed evaluation. TCS (n = 3) demonstrated nigral hyperechogenicity that was greater than controls [median area maximal substantia nigra echogenicity (aSNmax) = 0.28 cm 2 vs. 0.14 cm 2, P = 0.005], but similar to idiopathic PD (aSNmax = 0.31 cm 2). FDG PET (n = 2) demonstrated hypermetabolism of the lentiform nuclei, and F‐fluorodopa PET (n = 2), bilateral reduction in striatal F‐dopa uptake. Olfaction was markedly impaired in the two tested cases, including onset of smell disturbance in adolescence in one. Neuropsychological features (n = 3) were consistent with Parkinson's disease (PD) or diffuse Lewy body disease (DLB). The imaging, neuropsychological and olfactory markers suggest the GD phenotype includes PD with and without features of DLB, marked olfactory loss, nigral hyperechogenicity on TCS, and F‐dopa and FDG PET abnormalities. © 2010 Movement Disorder Society

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/mds.23046

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 86

Metadata

Authors
Saunders‐Pullman, R., Hagenah, J., Dhawan, V., Stanley, K., Pastores, G., Sathe, S., Tagliati, M., Condefer, K., Palmese, C., Brüggemann, N., Klein, C., Roe, A., Kornreich, R., Ozelius, L., & Bressman, S.
Venue
Movement Disorders
Publisher
Wiley
Published
2010-07-23
Volume
25
Issue
10
Pages
1364-1372
ISSN
  • 0885-3185 (ISSN-L)
  • 1531-8257
OpenAlex
W2066498624
Cited by
86
References
4
FWCI
4.18
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Gaucher disease ascertained through a Parkinson's center: Imaging and clinical characterization. https://app.cochat.ai/papers/10.1002/mds.23046
The paper
Saunders‐Pullman, R., Hagenah, J., Dhawan, V., Stanley, K., Pastores, G., Sathe, S., Tagliati, M., Condefer, K., Palmese, C., Brüggemann, N., Klein, C., Roe, A., Kornreich, R., Ozelius, L., & Bressman, S. (2010). Gaucher disease ascertained through a Parkinson's center: Imaging and clinical characterization. Movement Disorders. https://doi.org/10.1002/mds.23046

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.